<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><meta name="description" content="This function evaluates the clinical risk for direct (reversible) CYP
inhibition according to the basic model defined in the relevant regulatory
guideines."><title>Basic CYP inhibition risk — basic_cyp_inhibition_risk • ddir</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Basic CYP inhibition risk — basic_cyp_inhibition_risk"><meta property="og:description" content="This function evaluates the clinical risk for direct (reversible) CYP
inhibition according to the basic model defined in the relevant regulatory
guideines."><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">ddir</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.9.2</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
      </ul><form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off"></form>

      <ul class="navbar-nav"></ul></div>

    
  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="" class="logo" alt=""><h1>Basic CYP inhibition risk</h1>
      
      <div class="d-none name"><code>basic_cyp_inhibition_risk.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>This function evaluates the clinical risk for direct (reversible) CYP
inhibition according to the basic model defined in the relevant regulatory
guideines.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">basic_cyp_inhibition_risk</span><span class="op">(</span><span class="va">perp</span>, <span class="va">cyp_inh</span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="arguments">Arguments<a class="anchor" aria-label="anchor" href="#arguments"></a></h2>
    <dl><dt>perp</dt>
<dd><p>The perpetrator object.</p></dd>


<dt>cyp_inh</dt>
<dd><p>CYP inhibition data as data frame.</p></dd>

</dl></div>
    <div class="section level2">
    <h2 id="value">Value<a class="anchor" aria-label="anchor" href="#value"></a></h2>
    

<p>A data frame.</p>
    </div>
    <div class="section level2">
    <h2 id="details">Details<a class="anchor" aria-label="anchor" href="#details"></a></h2>
    <p>For the basic modeling of direct (reversible) CYP enzyme inhibition, the
ratios of the relevant inhibitor concentration to the \(K_i\) are
considered, i.e., \(R_1\) for hepatic enzymes and \(R_{1,gut}\) for
intestinal enzymes (refer to fig. 1 of  the the
<a href="https://www.fda.gov/media/134582/download" class="external-link">FDA guidance</a>). A threshold
of 1.02 applies.</p>
<p>Note that section 5.3.3.1 of the
<a href="https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-drug-interactions-revision-1_en.pdf" class="external-link">EMA DDI guidance</a>
defines the ratio as \(R_1=\frac{I_{max,ss,u}}{K_{i,u}}\) and the
threshold as 0.02.</p><div class="section">
<h3 id="liver">Liver<a class="anchor" aria-label="anchor" href="#liver"></a></h3>


<p>$$R_1=1+\frac{I_{max,ss,u}}{K_{i,u}}$$</p>
</div>

<div class="section">
<h3 id="gut-wall">Gut wall<a class="anchor" aria-label="anchor" href="#gut-wall"></a></h3>


<p>$$R_{1,gut}=1+\frac{I_{gut}}{K_{i,u}}$$</p>
<p>Refer to the documentation to the <code><a href="key_concentrations.html">key_concentrations()</a></code> function for details
on the calculation of \(I_{max,ss,u}\) and \(I_{gut}\).</p>
</div>

    </div>
    <div class="section level2">
    <h2 id="see-also">See also<a class="anchor" aria-label="anchor" href="#see-also"></a></h2>
    <div class="dont-index"><p><code><a href="basic_cyp_inhibition_risk_table.html">basic_cyp_inhibition_risk_table()</a></code></p>
<p><code><a href="key_concentrations.html">key_concentrations()</a></code></p></div>
    </div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="fu">basic_cyp_inhibition_risk</span><span class="op">(</span><span class="va">examplinib_parent</span>, <span class="va">examplinib_cyp_inhibition_data</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     param   ki  kiu    r1 risk_hep r1gut risk_intest</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1  CYP1A2   NA   NA    NA       NA    NA          NA</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2  CYP2B6   NA   NA    NA       NA    NA          NA</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3  CYP2C8 11.0 11.0 1.015    FALSE    NA          NA</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4  CYP2C9 13.5 13.5 1.012    FALSE    NA          NA</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 5 CYP2C19 15.0 15.0 1.011    FALSE    NA          NA</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6  CYP2D6   NA   NA    NA       NA    NA          NA</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7  CYP3A4 12.5 12.5 1.013    FALSE 293.3        TRUE</span>
<span class="r-in"><span></span></span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p></p><p>Developed by Rainer Strotmann.</p>
</div>

<div class="pkgdown-footer-right">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.7.</p>
</div>

    </footer></div>

  

  

  </body></html>

